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E-mail address: titoh@nara.kindai.ac.jp (T. Itoh).MicroRNAs (miRs) regulate several biological functions such as cell growth, cell differentiation, and
carcinogenesis, by binding to the 30-untranslated regions (30-UTR) of speciﬁc target genes, in order to
repress translation or promote degradation of the transcribed mRNAs. In the present study, using
microRNA array and in silico analyses, we found that miR-370 regulates the expression of bone mor-
phogenetic protein-2 (BMP-2) and V-ets Erythroblastosis Virus E26 Oncogene Homolog 1 (Ets1) in
BMP-2-stimulated murine pre-osteoblast MC3T3-E1 cell differentiation. The enforced expression
of mature miR-370 in MC3T3-E1 cells or primary osteoblast cells remarkably attenuated BMP-2-
induced pre-osteoblast differentiation. To ascertain the mechanisms underlying the regulation of
osteoblast differentiation by miR-370, we hypothesized a BMP-2-Ets1-PTHrP feed-forward loop reg-
ulatory mechanism.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
MicroRNAs (miRs) are non-coding RNAs that are approximately
18–25 nucleotides in length, derived from genome-encoded stem-
loop precursors, and act as important regulators in both animal
and plant development [1–3]. Mature miRs regulate the repression
of speciﬁc target gene translation and/or promote degradation of
transcribed mRNAs by binding to the 30-untranslated regions
(30-UTR) of the target genes. In the recent past, several reports have
indicated that miRs are closely implicated in diverse biological
processes, including cell growth, cell differentiation, apoptosis, car-
cinogenesis, and diabetes [4–8]. In osteogenesis, several miRs—
such as miR-138, miR-206, and miR-210—regulate osteoblast
differentiation [9–11]. We also found that miR-141, miR-200a,
and miR-208 regulate BMP-2-stimulated murine pre-osteoblast
MC3T3-E1 cell differentiation [12,13]. Thus, miR expression
machinery is one of the key regulatory mechanisms in
osteogenesis.chemical Societies. Published by E
bone morphogenetic protein-
Homolog 1; miR, microRNA;
factor 2; PTHrP, parathyroidIn the miR expression proﬁle data collected by us from BMP-2-
treated MC3T3-E1 cells, we found that miR-370 expression levels
in these cells were signiﬁcantly decreased relative to non-BMP-2-
treated cells. In the present study, we have identiﬁed miR-370 tar-
get molecules in BMP-2-stimulated MC3T3-E1 cells. In silico anal-
yses showed that BMP-2 and V-ets Erythroblastosis Virus E26
Oncogene Homolog 1 (Ets1) could be candidate target genes of
miR-370. We veriﬁed the results obtained from the in silico analy-
ses withWestern blot analysis, real-time PCR, and sensor luciferase
reporter assays. Our ﬁndings present additional evidence that the
expression of BMP-2 and Ets1 during the early stages of
BMP-2-stimulated MC3T3-E1 cell differentiation is because of
downregulated miR-370.2. Materials and methods
2.1. Materials
Bioactive recombinant human BMP-2 was obtained from R&D
systems (MN, USA). Eagle’s a-minimal essential medium (a-
MEM), OPTI-MEM, fetal bovine serum (FBS), and Lipofectamine™
RNAi MAX were purchased from Invitrogen (Carlsbad, CA, USA).
Alkaline phosphatase (ALP) assay kit LabAssay™ALP was obtained
from WAKO Pure Chemical Industries Ltd. (Osaka, Japan). Alkaline
phosphatase staining kits (TRAP & ALP double-stain kit) werelsevier B.V. All rights reserved.
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Ets1, BMP-2, runt-related transcription factor 2 (Runx2), and
Osteopontin (OPN), were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA, USA).
2.2. Cell culture
The murine pre-osteoblast cell line MC3T3-E1 was obtained
from RIKEN Cell Bank (Tsukuba, Ibaraki, Japan). Primary murine
osteoblast (P-MOB) cells, isolated from ICR mouse calvaria, were
purchased from Primary Cell Co. Ltd. (Sapporo, Hokkaido, Japan).
These cells were cultured in a humidiﬁed atmosphere at 37 C con-
sisting of 5% CO2, in phenol-red free a-MEM supplemented with
10% heat-inactivated FBS, 100 ng/ml of penicillin, and 100 lg/ml
streptomycin. For experiments, 100 ng/ml BMP-2 in PBS was added
to the culture medium.2.3. microRNA array hybridization
The protocols for delineating the expression proﬁles of miRs
have been described in a previous report [12].
2.4. Quantitative RT-PCR
To conﬁrm the reproducibility of miR expression proﬁles as
examined by miR array analysis, we measured miR expression lev-
els by using a TaqMan microRNA Reverse Transcription Kit and
TaqMan microRNA Assay Kit (Applied Biosystems, Foster City,
CA, USA). Brieﬂy, total RNA was extracted from the cells by TRIzol
containing phenol/guanidium isothiocyanate (Invitrogen) with
DNase I treatment, and complementary DNA (cDNA) was then syn-
thesized from a reverse-transcriptase (RT) reaction with 12.5 ng of
total RNA. The RT products were subjected to quantitative RT-PCR
(qRT-PCR) using a Thermal Cycler Dice real-time PCR system
TP800 (Takara Bio). Expression levels were normalized to U6,
which was used as an internal control, and quantiﬁed by theFig. 1. Time-dependent expression of miR-370 in BMP-2-induced pre-osteoblast differen
expression levels in MC3T3-E1 cells until 21 days after BMP-2 stimulation (left panel).
within 3 days (this panel is an enlarged portion of the dotted square in left panel.) Thecomparative Ct (DD Ct) method [14]. The qRT-PCR reaction con-
sisted of 45 cycles—95 C for 10 s, 60 C for 40 s, and 72 C for
1 s—after an initial denaturation step (95 C for 10 min).
To determine the levels of BMP-2 and Ets1 mRNA, we prepared
cDNA from total RNA samples by using a PrimeScript™ reagent Kit
(Takara Bio). Subsequently, qRT-PCR was performed (Thermal
Cycler Dice TP800) by using a SYBERPremix Taq™ II Kit (Takara)
and the following primer sets: BMP-2-sense, and BMP-2-antisense;
Ets1-sense, 50-CTCTCCAGACAGACACCTTGC-30 and Ets1-antisense,
50-AGCACGGTCACGCACATA-30. Glyceraldehyde phosphate dehydro-
genase (GAPDH) cDNA was used as an internal control.
2.5. Transfection ofMC3T3-El cells with miRNAs
MC3T3-E1 cells were seeded in 6-well plates at 1  105
cells ml1 well1 the day before transfection. The mature type of
miR-370 (Applied Biosystems; sequence: GCCUGCUGGGGUGGA
ACCUGGU, Fig. 1A), and its antisense inhibitor (Applied Biosys-
tems)—designed to bind to and inhibit the activity of endogenous
speciﬁc miRNAs when introduced into cells—were transfected into
the MC3T3-E1 cells by using cationic liposomes (RNAiMAX),
according to the manufacturer’s lipofection protocol. The transfec-
tion efﬁciency was >80% as evaluated by transfecting cells with an
Alexa Fluor 488 (Molecular Probes)-conjugated dextran molecular
probe (data not shown). Non-speciﬁc control miR (Applied Biosys-
tems) was used as the control for non-speciﬁc antibody binding.
The culture medium containing 10% FBS, 100 U/ml penicillin, and
100 lg/ml streptomycin was changed 12 h post transfection.
Transfected cells were cultured for 3 days, and then reseeded for
various experiments at 1  105 cells/ml.2.6. ALP activity and ALP staining
We used ALP as a marker for osteoblast differentiation. The pro-
tocols for ALP activity assay and ALP staining have been described
in a previous report [12].tiation. (A) The sequence of stem-loop structured miR-370. (B) Changes in miR-370
The right panel shows the change in miR-370 expression levels in MC3T3-E1 cells
value of the cells before BMP-2 treatment was designated as 1.
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We used the level of alizarin red staining as a marker for min-
eralization. The protocols for this procedure have been described
in a previous report [12].2.8. Western blotting
Cell lysates were prepared as described previously [12]. Each
whole cell lysate was resuspended in sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) buffer containing
2% 2-mercaptoethanol, and boiled at 98 C for 5 min. Protein
samples were subjected to SDS–PAGE in a 12% polyacrylamide
gel, and subsequently electroblotted onto a polyvinylidene ﬂuo-
ride (PVDF) membrane (GE Healthcare, NJ, USA). After blocking
non-speciﬁc binding sites for 1 h in 5% nonfat milk in TPBS
(PBS and 0.1% Tween 20), the membrane was incubated over-
night at 4 C with various primary antibodies. The membrane
was then washed 3 times in TPBS, incubated further with horse-
radish peroxidase-conjugated secondary antibody at room tem-
perature, and then washed again 3 times in TPBS. Protein
bands were detected using an enhanced ECL kit (GE Healthcare)
and chemiluminescence detector (LAS-4000; Fujiﬁlm, Japan).Fig. 2. Effects of transfection with mature or antisense inhibitor for miR-370 on the diffe
with miR-370 or antisense inhibitor for miRNA-370 was determined via ALP staining after
signiﬁcant sequence similarity to mouse, rat, or human transcription products. (B) Overe
(i) Time course of ALP activity and (ii) dose dependency (treatment time: 72 h). Cells
mean ± S.E. of 3 separate experiments. Statistical signiﬁcance is considered at p < 0.01, a
MC3T3-E1 cells transfected with miR-370 or the antisense inhibitor for miRNA-370 was2.9. Luciferase assay
To determine target regions for miR-370 in BMP-2 and Ets1, we
constructed pGL3-BMP-2/miR370 and pGL3-Ets1/miR-370 sensor
plasmids either by inserting a candidate binding site in the 30-
untranslated region (30-UTR) of BMP-2 or by introducing Ets1
mRNA into the XbaI site of the pGL3 control vector (Promega, Mad-
ison, WI, USA).
ThePCRprimer sequences used for construction of thepGL3-Ets1
sensor plasmids are asfollows: pGL3-BMP-2/miR-370 sensor sense,
50-GCTCTAGAGCTGGGTTCAACTCCAGCACAT-30, pGL3-BMP-2/miR-
370 sensor-A antisense, 50-GCTCTAGAGCATTTAGTACTTTGG CCA-
GAT-30; pGL3-Ets1/miR-370 sensor sense, 50-GCTCTAGAGCATGCT-
GATCTGGGGACAGGG- 30, pGL3-Ets1/miR-370 sensor antisense, 50-
GCTCTAGAGCTGCATTACACTCCACTTTCA-30.
We also constructed vectors containing mutated miR-370 com-
plementary sites in BMP-2 or Ets1 by using a PrimeStar™ mutagen-
esis basal kit (Takara). The PCR primer sequences used for
construction of the mutated pGL3-BMP-2 or Ets1/miR-370 sensor
plasmid are as follows: pGL3-BMP-2/miR-370 sensor-B Mut sense,
50-CAAGAACAACTACTTACCAGTGGGAATAATTAGGAAACC-30 and
antisense, 50-CCCACTGGTAAGTAGTTGTTCTTGCTGCAGGGAGGGTG
G-30; pGL3-Ets1/miR-370 sensor-B Mut: sense, 50-AATCCAAGGC-
TACTTATTAACCTGGGTTTTGGTTAAACC- 30 and antisense, 50-CAGGrentiation of MC3T3-E1 cells. (A) The differentiation of MC3T3-E1 cells transfected
treatment with BMP-2. Negative control miR-NC (miR-NC) was designed to have no
xpression of mature miR-370 in MC3T3-E1 cells signiﬁcantly increased ALP activity;
were treated with 100 ng/ml BMP-2. Values for each group are expressed as the
s determined by Fisher’s multiple range test. (C) Mineralization of differentiation in
observed by Alizarin red staining after treatment with BMP-2.
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were seeded into 12-well plates (at 1  105 cells/ml), and subse-
quently cultured for 2 days after using Lipofectamine™ RNAiMAX
to co-transfect the cells with pRL-SV40 vector, 40 nM miR-208,
and the sensor vector plasmid or the mutated sensor vector. Lucif-
erase activity was measured using the Luciferase Assay System
(Promega), according to the manufacturer’s protocol. Relative lucif-
erase activity was expressed as the ratio of measured luciferase
activity to control (non-speciﬁc miR).2.10. Statistical analysis
All data were analyzed by one-way analysis of variance (ANO-
VA), and subsequently by Fisher’s multiple range test among many
groups, or Student’s t-test between two groups, at a signiﬁcance le-
vel of p < 0.05.Fig. 3. Expression of BMP-2 or Ets1 during BMP-2-stimulated osteoblast differentiation
shown. The position of the binding sites was numbered relative to the ﬁrst nucleotide in e
within the BMP-2 or Ets1 30-UTR is shown. The light shadow site denotes perfectly conse
independent experiments showing, in BMP-2-treated MC3T3-E1 cells, the time course of
Ets1mRNA expression. Values for each group are expressed as the mean ± S.E. of three sep
Fisher’s multiple range test.Statistical analyses were carried out using StatView 5.0 soft-
ware (SAS Institute, Cary, NC).
3. Results
3.1. Expression proﬁle of miR-370 in BMP-2-induced pre-osteoblast
MC3T3-E1 cell differentiation
To investigate the expression proﬁles of miRs in BMP-2-treated
MC3T3-E1 cells, we extracted total RNA from both BMP-2-treated
and non-treated cells 24 h after treatment, and placed the samples
on Genopal-MICH chips. The expression levels of miR-370 were
signiﬁcantly downregulated (log ratio >1.5) in the BMP-2-treated
relative to non-treated cells. To conﬁrm the results of the miRNA
array analysis, we examined time-dependent expression levels of
miR-370 in BMP-2-treated and non-treated cells by TaqMan
real-time PCR. As presented in Fig. 1B, miR-370 expression in. (A) Putative miR-370 binding sites within the mouse BMP-2 and Ets1 30-UTR are
ach mRNA sequence. (B) Interspecies conservation of putative miR-370 binding sites
rved sequences between mouse and other species. Representative blots from three
(C) BMP-2 or Ets1 protein expression (with 20 lg of protein/lane) and (D) BMP-2 or
arate experiments. Statistical signiﬁcance is considered at p < 0.01, as determined by
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relative to non-treated cells. However, miR-370 expression gradu-
ally increased approximately 2-fold from day 1 to day 14, and
thereafter returned to basal levels on day 21.
3.2. Effects of miR-370 in BMP-2-stimulated MC3T3-E1 cell
differentiation
ALP activity increases in a time-dependent manner in MC3T3-
E1 cells after treatment with BMP-2 (1). To investigate the role of
miR-370 during differentiation, we measured ALP activity after
transfection with miR-370 or antisense inhibitor for miR-370. As
shown in Fig. 2A, B-i, and B-ii, ALP activity in cells transfected with
miR-370 was lower relative to that in the non-treated cells. More-
over, miR-370 inhibited osteoblast differentiation in a concentra-
tion-dependent manner. On the other hand, the activity in cells
transfected with an antisense inhibitor for miR-370 was un-
changed relative to the non-treated cells. We further examined
mineralization as assessed by Alizarin red staining in cells transfec-
ted with miR-370. The levels of mineralization in the cells transfec-
ted with miR-370 were slightly suppressed compared to those in
cells transfected with miR-NC or antisense inhibitor for miR-370,
and non-treated MC3T3-E1 cells (Fig. 2C).Fig. 4. Expression of BMP-2 and Ets1 is translation ally regulated by miR-370
during osteoblast differentiation. Representative Western blots from three inde-
pendent experiments showing (with 20 lg of protein/lane) (A) downregulated
expression of BMP-2 and Ets1 protein in MC3T3-E1 cells transfected with miR-370,
and (B) that the antisense inhibitor for miR-370 did not affect BMP-2 or Ets1
expression after 3-day treatment with BMP-2 (100 ng/ml). A representative
Western blot from three independent experiments is shown. (C) Changes in BMP-
2 and Ets1mRNA expression in cells transfected with miR-370, as examined by qRT-
PCR. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal
control. Values for each group are expressed as the mean ± S.E. of three separate
experiments. Statistical signiﬁcance is considered at p < 0.01, as determined by
Fisher’s multiple range test.3.3. BMP-2 and Ets1 are target genes of miR-370 as shown by in silico
analyses
To determine the target genes of miR-370 in BMP-2-stimulated
osteoblast differentiation, we searched for candidate genes using
miRBase Target Version 5.2 and miRanda databases. BMP-2 and
Ets1 were selected as candidate target genes from 2850 target
genes of miR-370 (Fig. 3A). As shown in Fig. 3B, whereas numerous
species have common AGCAGG binding sites for Mmu-miR-370 in
the BMP-2 30-UTR region, this sequence was found only in the 30-
UTR region of mmu-Ets1 mRNA (Fig. 3B). Therefore, miR-370 prob-
ably does not act as an Ets1 regulator in human cells.
The MC3T3E-1 cells used in this study displayed gradually
upregulated expression of BMP-2 and Ets1 proteins after BMP-2
stimulation (Fig. 3C). Furthermore, the levels of BMP-2 and Ets1
mRNA also showed a consistent increase for up to 72 h (Fig. 3D).
3.4. MicroRNA-370 overexpression inhibits the expression of BMP-2
and Ets1
To investigate the role of miR-370 in BMP-2-stimulated osteo-
blast differentiation, we examined BMP-2 and Ets1 protein expres-
sion by using Western blot analysis. Expression of both BMP-2 and
Ets1 proteins was downregulated in cells transfected with miR-370
(Fig. 4A). In particular, the suppression levels of BMP-2 were great-
er than those of Ets 1. In contrast, BMP-2 and Ets1 protein expres-
sion—in cells transfected with the antisense inhibitor for
miR-370—did not change compared to both control miR-NC and
BMP-2-stimulated cells (Fig. 4B). As assessed by qRT-PCR and
semi-qRT-PCR, the levels of BMP-2 and Ets1mRNA in cells transfec-
ted with miR-370 showed no obvious change compared to both
control miR-NC and BMP-2-stimulated cells (Fig. 4C). Therefore,
these ﬁndings suggest that the suppression of BMP-2 and Ets1
expression by miR-370 was due to direct inhibition of translation.
We further examined the expression of OPN and Runx2, which
are well known as BMP-2- or Ets1-controlled downstream mole-
cules [15,16]. As shown in Fig. 5, the expression level of OPN at
day 10 was signiﬁcantly decreased in the cells transfected with
miR-370 compared to both control miR-NC and BMP-2-stimulated
cells. Moreover, the expression levels of Runx2 and PTHrP at day 3
were slightly decreased in the cells transfected with miR-370 com-
pared to both control miR-NC and BMP-2-stimulated cells.Fig. 5. Changes in the protein expression of the downstream molecules OPN,
Runx2, and PTHrP in cells transfected with miR-370 following BMP-2 stimulation. A
representative Western blot from three independent experiments showing (with
20 lg of protein/lane) OPN, Runx2, and PTHrP expression in BMP-2-treated MC3T3-
E1 cells.
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To determine the target regions of miR-370 in BMP-2 and Ets1
mRNA, we constructed several luciferase reporter plasmids, each
containing one possible miR-370-binding region (Fig. 6A). The lev-
els of luciferase activity in pGL3-BMP-2/miR-370 and pGL3-Ets1/
miR-370 sensors, which contained the sequence 2055–2077 from
the BMP-2 30-UTR region and the sequence 2630–2652 from the
Ets1 30-UTR region, respectively, were signiﬁcantly lower than
those in the non-speciﬁc control sensor vector (Fig. 6B). However,
the level of luciferase activity for the miR-370 mutant-binding site
in the pGL3-BMP-2 or pGL3-Ets1/miR-370 sensors was not re-
duced. These results, thus, indicate that target regions in BMP-2
and Ets1 are miR-370 binding sites.
3.6. Effects of miR-370 on the differentiation of primary murine
osteoblast cells
We examined the role of miR-370 during BMP-2-induced
osteoblast differentiation in primary murine osteoblast (P-MOB)
cells. The ALP activities in cells transfected with miR-370 wereFig. 6. Identiﬁcation of the target gene for miRNA-370 by luciferase reporter assay. (A)
identiﬁcation of target regions in BMP-2 or Ets1 for miR-370. Construction of two kinds (
(B) The mutated region corresponding to the seed sequence of miR-370 sensor vectors w
into the seed regions of each binding site as indicated by the dotted box. (C) Each sensor v
After 24 h, ﬁreﬂy and Renilla luciferase activities were measured using the Luciferase Assa
calculated as the ratio of ﬁreﬂy to Renilla luciferase activity. Values for each group are
considered at ⁄p < 0.01, as determined by Student’s t test; p < 0.05 was considered signisigniﬁcantly suppressed (Supplementary Fig. 1). These results
suggest that downregulation of miR-370 in BMP-2-stimulated
osteoblast differentiation is a part of the crucial regulatory and dif-
ferentiation-promoting machinery of a cell.
4. Discussion
To the best of our knowledge, this is the ﬁrst study to show that
miR-370 directly regulates BMP-2 and Ets1 expression, at the
translational level, during BMP-2-stimulated MC3T3-E1 cell differ-
entiation. The enforced expression of miR-370 in P-MOB cells also
signiﬁcantly attenuated BMP-2-stimulated osteoblast differentia-
tion, suggesting that downregulation of miR-370 is an important
common phenomenon for osteoblast differentiation.
BMP-2 is well known as one of the most powerful osteogenesis-
promoting proteins [17–19]. During osteoblast differentiation,
BMP-2 binds to 2 types of serine/threonine kinase receptors—
BMPR Type I and Type II—subsequently initiating the BMP
signaling pathway [20–22]. First, BMP signaling activates recep-
tor-regulated Smads (R-Smad; Smadl, Smad5, and Smad8), which,
in turn, form a complex with common mediator Smads (Co-Smad;Schematic representation of the sensor vectors used in the luciferase assay for the
A or B) of luciferase reporter plasmids, including the 30-UTR of BMP-2 or Ets1mRNA.
as made from pGL3-BMP-2 or pGL3-Ets1 30-UTR sensors. Mutations were introduced
ector, pRL-SV 40, and miR-NC or miR-370, were co-transfected into MC3T3-E1 cells.
y System (Promega), according to the manufacturer’s protocol. The miR activity was
expressed as mean ± S.E. of three separate experiments. Statistical signiﬁcance is
ﬁcant for our analyses.
Fig. 6 (continued)
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into the nucleus, where it regulates target genes such as OPN, oste-
ocalcin (OCN), ALP, and Runx2. The Ets1 proto-oncogene, a member
of the Ets family, was originally found in a study of the avian E26
retroviral genome [23–25]. The Ets transcription factor family is
closely involved in the regulation of cell differentiation [26],
metastasis [17], apoptosis [27], and angiogenesis [28], and plays
critical roles in osteogenesis [29]. Vary et al. indicated that Ets1
is highly expressed during the proliferation stage in BMP-2-stimu-
lated MC3T3-E1 cells [30]. Furthermore, Ets1 expression is modu-
lated by protein kinase C (PKC), p38 mitogen-activated protein
(MAP) kinase, retinoic acid, Ets1/AP-1 interaction, and activation
of the Ras/Raf/mitogen-activated protein kinase/extracellular sig-
nal-regulated kinase (ERK, MEK)/ERKl/2 signaling pathway. Conse-
quently, this leads to the transactivation of target genes such as
OPN, PTHrP, Runx2, tenascin-C (a polymorphic high-molecular mass
extracellular matrix glycoprotein that is secreted from osteoblasts
during osteogenesis), and type I procollagen [15,16,23,31–36]. We
also indicated in a previous report that Ets1 expression following
BMP-2 stimulation was partially due to the downregulation of
miR-208 [15]. Hence, both BMP-2 and Ets1 are pivotal molecules
in osteoblast differentiation.
To identify the regulatory mechanisms underlying the regula-
tion of osteoblast differentiation by miR-370, we hypothesized
the BMP-2-Ets1-PTHrP feed-forward loop regulatory mechanism
(Supplementary Fig. 2). In osteoblasts, parathyroid hormone
(PTH) upregulates BMP-2mRNA expression through the PTH-cyclic
AMP response element-binding protein (CREB) signaling pathway
[37,38]. Since PTHrP also binds to the PTH receptor (PTHR), whichis expressed in the osteoblast cell membrane, the same PTH-CREB
signal transduction pathway is activated [39–41]. When we exam-
ined the activity of the cAMP/CREB pathway in the BMP-2-stimu-
lated MC3T3-E1 cells or BMP-2-stimulated MC3T3-E1 cells
transfected with miR-370 by using a pGL4.29 [luc2P//CRE/Hygro]
dual luciferase reporter assay system (Promega), the levels of lucif-
erase activity in cells transfected with miR-370 was signiﬁcantly
attenuated compared to that in normal cells (Supplementary
Fig. 3). Thus, PTHrP may have upregulated BMP-2 mRNA expres-
sion in this study. Ets1 also activates PTHrP gene expression via
the binding of CREB to the PTHrP P3 promoter region [42,43]. From
the above-mentioned data, we concluded that BMP-2, Ets1, and
PTHrP organized the feed-forward loop in BMP-2-stimulated
MC3T3-E1 cells. The results of the Western blot analysis showed
that miR-370 inhibited the expression of Ets1 and BMP-2. The
expression level of PTHrP in the cells transfected with miR-370
was also slightly suppressed relative to non-treated BMP-2-stimu-
lated MC3T3-E1 cells. These results may support the view that Ets1
regulates PTHrP expression, and organizes the BMP-2-Ets1 -PTHrP
feed-forward loop during differentiation. However, the levels of
BMP-2 and Ets1 in the cells transfected with miR-370 were un-
changed relative to those in the non-treated cells or the MC3T3-
E1 cells transfected with miR-NC, and/or stimulated with BMP-2.
Our ﬁndings thus suggest that miR-370 directly affects the expres-
sion of BMP-2 and Ets1 at the translational level. If the BMP-2-
Ets1-PTHrP feed-forward loop had played a role in BMP-2-stimu-
lated MC3T3-E1 cell differentiation, the levels of BMP-2 and Ets1
in cells transfected with miR-370 should have been detected to a
lesser extent compared to non-treated cells, or MC3T3-E1 cells
1700 T. Itoh et al. / FEBS Letters 586 (2012) 1693–1701transfected with miR-NC, and/or stimulated with BMP-2. As we did
not observe this, further examination is needed to shed light on
this discrepancy in the hypothesis.
Davis et al. reported that Smad proteins bind a conserved RNA
sequence to regulate miRNA processing [44,45]. Drosha-mediated
pri-miRNA processing requires the p68 and p72 subunits of the
DEAD-box RNA helicase, and the p68 subunit interacts with Smad.
Sato et al. also reported that Smadl/Smad4 regulate the processing
of pri-miR-206 into miR-206 [46]. In the present study, the expres-
sion levels of miR-370 were gradually downregulated during the
early osteoblast differentiation stage (Fig. 1B). Since Smad activa-
tion initiates signal transduction in BMP signaling, downregulation
of miR-370 expression may also be closely involved in BMP signal-
ing (Smad activation). On the other hand, miR-370 expression in-
creased gradually from day 1 to day 14 (Fig. 1B). This change is
probably an example of the regulatory machinery that is activated
to ensure stable osteoblast differentiation. Moreover, Runx2 acts as
a suppressor molecule during the late stage of osteogenesis [16].
Therefore, excessive expression of Runx2 is not conducive for
osteoblast differentiation. It was thus concluded that elevated
miR-370 expression from day 1 to day 14 in BMP-2-stimulated
MC3T3-E1 cells acted to suppress Runx2 expression, which is pos-
itively regulated by BMP2 and Ets1 during the later stages of
osteogenesis.
In conclusion, we found that miR-370 regulates BMP-2-stimu-
lated mouse pre-osteoblast differentiation by targeting BMP-2
and Ets1. Therefore, the regulation of miR-370 would be beneﬁcial
for osteogenic disorders.
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